HomeJUNS • NASDAQ
Jupiter Neurosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 401.64K | -66.60% |
Net income | -591.02K | 66.69% |
Net profit margin | — | — |
Earnings per share | -0.02 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 253.00 | — |
Total assets | 85.55K | — |
Total liabilities | 5.84M | — |
Total equity | -5.75M | — |
Shares outstanding | 33.10M | — |
Price to book | -3.36 | — |
Return on assets | -1,110.11% | — |
Return on capital | 38.57% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -591.02K | 66.69% |
Cash from operations | -42.60K | 73.89% |
Cash from investing | — | — |
Cash from financing | 28.00K | -85.64% |
Net change in cash | -14.60K | -145.87% |
Free cash flow | -21.61K | — |
Previous close
$0.64
Day range
$0.59 - $0.63
Year range
$0.55 - $19.51
Market cap
19.74M USD
Avg Volume
132.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
4
